FDA-Drug2026-09-02Class IIMISBRANDING
Accord Healthcare Levothyroxine Sodium 300 mcg tablets recalled for subpotency
What this means
Accord Healthcare is recalling one lot of Levothyroxine Sodium 300 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and subpotent tablets may not work as intended to treat thyroid conditions.
- Check if you have lot #D2402337 with expiration date 10/31/2026 (NDC 16729-458-15).
- Contact your pharmacy or doctor if you have this lot — do not stop taking your medication without medical guidance.
- Your pharmacist can verify your prescription and provide a replacement if needed.
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0786-2026More Accord Healthcare recalls
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare levothyroxine 100 mcg tablets recalled for subpotency
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium 150 mcg tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare Levothyroxine Sodium 175 mcg tablets recalled for subpotency
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.